120 related articles for article (PubMed ID: 14724045)
1. Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents.
Ferreri G; Chimirri A; Russo E; Gitto R; Gareri P; De Sarro A; De Sarro G
Pharmacol Biochem Behav; 2004 Jan; 77(1):85-94. PubMed ID: 14724045
[TBL] [Abstract][Full Text] [Related]
2. Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents.
De Sarro G; Ferreri G; Gareri P; Russo E; De Sarro A; Gitto R; Chimirri A
Pharmacol Biochem Behav; 2003 Feb; 74(3):595-602. PubMed ID: 12543224
[TBL] [Abstract][Full Text] [Related]
3. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Yamaguchi S; Donevan SD; Rogawski MA
Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
[TBL] [Abstract][Full Text] [Related]
6. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
7. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG
J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300
[TBL] [Abstract][Full Text] [Related]
8. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
9. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
Chapman AG; Smith SE; Meldrum BS
Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist.
Gitto R; Barreca ML; De Luca L; De Sarro G; Ferreri G; Quartarone S; Russo E; Constanti A; Chimirri A
J Med Chem; 2003 Jan; 46(1):197-200. PubMed ID: 12502375
[TBL] [Abstract][Full Text] [Related]
11. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.
Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C
J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticonvulsant properties of tetrahydroisoquinoline derivatives.
Gitto R; Caruso R; Orlando V; Quartarone S; Barreca ML; Ferreri G; Russo E; De Sarro G; Chimirri A
Farmaco; 2004 Jan; 59(1):7-12. PubMed ID: 14751310
[TBL] [Abstract][Full Text] [Related]
13. Aniracetam reverses the anticonvulsant action of NBQX and GYKI 52466 in DBA/2 mice.
Chapman AG; al-Zubaidy Z; Meldrum BS
Eur J Pharmacol; 1993 Feb; 231(2):301-3. PubMed ID: 8453982
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.
Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puia G; Baraldi M; De Micheli C
J Med Chem; 1999 Oct; 42(21):4414-21. PubMed ID: 10543885
[TBL] [Abstract][Full Text] [Related]
15. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice.
Zarnowski T; Kleinrok Z; Turski WA; Czuczwar SJ
Neuropharmacology; 1993 Sep; 32(9):895-900. PubMed ID: 7694171
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticonvulsant activity of N-3 substituted 2,3-benzodiazepines.
Quartarone S; Caruso R; Orlando V; Russo E; De Sarro G; Chimirri A
Farmaco; 2004 May; 59(5):353-8. PubMed ID: 15120314
[TBL] [Abstract][Full Text] [Related]
17. NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.
De Sarro G; Siniscalchi A; Ferreri G; Gallelli L; De Sarro A
Eur J Pharmacol; 2000 Nov; 408(1):25-34. PubMed ID: 11070180
[TBL] [Abstract][Full Text] [Related]
18. Influence of LY 300164, an AMPA/kainate receptor antagonist upon the anticonvulsant action of antiepileptic drugs against aminophylline-induced seizures in mice.
Swiader M; Kuźniar H; Kleinrok Z; Czuczwar SJ
Pol J Pharmacol; 2003; 55(1):103-7. PubMed ID: 12856833
[TBL] [Abstract][Full Text] [Related]
19. Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.
De Sarro G; Renne S; Nava F; De Sarro A
J Pharm Pharmacol; 1994 Dec; 46(12):1017-22. PubMed ID: 7714713
[TBL] [Abstract][Full Text] [Related]
20. NMDA and not non-NMDA receptor antagonists are protective against seizures induced by homocysteine in neonatal rats.
Folbergrová J
Exp Neurol; 1994 Dec; 130(2):344-50. PubMed ID: 7867764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
